Tip: Try author name, DOI (10.xxxx/…), or keywords.

ISSN (Online): 1694-4674
  1. Home
  2. Vol. 05, No. 09, (2026)
  3. Fungating Dermatofibrosarcoma Protuberans of the Breast
Case Series Open Access

Fungating Dermatofibrosarcoma Protuberans of the Breast

,,
Annals of Medicine and Medical SciencesVol. 05, No. 09, (2026) September 8, 2026pp. 2164 - 2167

Abstract

Dermatofibrosarcoma protuberans is an uncommon cutaneous tumor that originates from the dermal fibroblasts. Dermatofibrosarcoma protuberans can develop in various parts of the body. However, it is rarely found in the breast, and few cases have been reported in the literature. Though locally aggressive in character but seldom metastasize. Main objective of the study is to share our experience with literature review of the Dermatofibrosarcoma protuberans of the breast. A 45-year-old female patient presented with painless left breast mass which was growing slowly over 5 years. The last 2 years it turned into an ulcerative lesion, and bleeding at times in past few months. On physical examination she was anemic and there was a big fungating ulcerating mass in the left breast involved all four quadrants of the breast with no axillary lymph node enlargement. The patient was offered a mastectomy. Histologically, confirmed as Dermatofibrosarcoma protuberans of the left breast with I mm clear of deep resection margins. Dermatofibrosarcoma protuberans of the breast is an uncommon condition and symptoms may mimic those of breast cancer. Dermatofibrosarcoma protuberans involves all four quadrants of the breast, necessitating a mastectomy. The recommended first-line treatment for resectable Dermatofibrosarcoma protuberans is surgical excision, with tumor free margin.

Keywords

Dermatofibrosarcoma protuberans (DFSP) Breast cancer.

Introduction

Dermatofibrosarcoma protuberans (DFSP) is an uncommon cutaneous tumor that originates from dermal fibroblasts. The condition was initially characterized in 1924 by Darier and Ferrand as a recurrent dermatofibroma and subsequently named as dermatofibrosarcoma protuberans in 1925 by Hoffmann [1,2]. Breast DFSP has typically been described as a superficial, oval or lobulated, relatively well-circumscribed mass without calcification [3]. It manifests as a painless, gradually enlarging subcutaneous nodule [4]. DFSP is locally aggressive with a tendency for local recurrence but rarely metastasizes [5]. It predominantly occurs in young to middle-aged adults with range of 17–48 years [6,7,8]. The disease and the symptoms may mimic those of breast cancer, and this poses a challenge on the diagnosis [9]. Mammograms and biopsy are required to assess the disease condition. Histopathology and immunohistochemistry (IHC) are essential investigations to confirm the disease [6]. When the diagnosis is confirmed, treatment is mainly surgical resection [4,10]. Main objective of the study is to share our experience with literature review of the Fungating Dermatofibrosarcoma protuberans of the breast. This case report has been structured in line with the CARE guidelines.

Case Report

A 45-year-old female patient presented with painless left breast mass which was growing slowly over 5 years. The last 2 years it turned into ulcerative lesion, and she observed that there was bleeding at times in past few months. The patient did not attend any hospital for breast lumps until the ulcerative lesion started bleeding. She received blood transfusion at the local hospital and later referred to Pietersburg academic hospital for further intervention. On physical examination she was anemic and there was a big fungating ulcerating mass (10 cm x 15 cm) in left breast involved all four quadrants of the breast. It was foul smelling and bleeding from ulcerative lesions was observed. There was no obvious enlargement of regional axillary lymph node on clinical examination. On plain Chest X-ray there was no metastasis in the lung and the left breast shadow was observed to be much bigger than the right (Fig 1). Mastectomy was performed. The gross histopathology revealed a breast tissue of 3100g with ulcerating polypoid tumor present on the surface of the skin measuring 300mm x185mm x 100mm. Histological examination demonstrated a spindle cell proliferation which displayed a herringbone growth pattern and involvement of the epidermis. 11 mitoses identified in ten high power fields with no representation of malignant glandular elements. There were areas of haemorrhage and necrosis. The tumour was 1mm from the deep resection margin. Immunohistochemical profile reflected CD34: diffuse membranous and cytoplasmic positivity within the tumour cells. BCL2: strong and diffuse cytoplasmic positive within the tumour cells, S100: isolated tumour cell positivity. The Diagnosis of DFSP was contemplated on histology. The post-operative course was uneventful and wound healed. Patient was discharged and advised to come for follow up in the surgical clinic and referred to oncology clinic as well. However, the patient defaulted to attend surgical clinic and oncology department for almost 2 years. Currently she visited the general surgery clinic for follow up. At present there was no obvious complaint. On clinical examinations, there are no signs of mass or recurrence observed on mastectomy sites. This time, Mammogram and Computer tomography (CT) scan were performed. The mammogram reported normal breast finding on the right breast and normal scar tissue in the left post mastectomy side. No sign of recurrence or no obvious chest wall mass was observed (Figure 2). CT (Figure 3) reflected no pulmonary metastasis and normal breast tissue (right) and post mastectomy scar (left). Patient was given follow up date for oncology and surgical clinic.

Figure 1
Figure 1 Chest X ray: 1A (PA view): Asymmetry of the breast shadow and no radiological evidence of pulmonary metastasis. Arrow shows left breast soft tissue density which is markedly enlarged. 1B (lateral view): The arrow highlights enlarged left breast.
Figure 2
Figure 2 Mammogram: 2A-right breast mammogram normal breast finding. 2B left breast mammogram scar tissue post mastectomy, no sign of recurrence or no obvious chest wall mass.
Figure 3
Figure 3 Computer tomography (CT) scan: No pulmonary metastasis. Normal breast tissue (right), post mastectomy scar (left)

Discussion

Dermatofibrosarcoma protuberans (DFSP) can develop in various parts of the body. However, DFSP is rarely found in the breast, and only a few cases have been reported in the literature [6]. The symptoms of DFSP may mimic those of breast cancer [9]. and modality of treatment of DFSP different from carcinoma of breast. Though DFSP is uncommon in breast, the typical mean age of presentation is approximately 30 years. [6]. In our case, the patient was 45-year-old and presented very late to the local hospital with fungating breast mass which mimic as breast cancer. Previous study from Limpopo found that most of the patients with breast mass presented late in health care facility and the time diagnosis breast cancer already advances stage (70%). The main reasons for the delay were lack of breast cancer knowledge, ignorance and painless breast mass [11]. Similarly, we see this patient also presented late until bleeding started from the fungating ulcerative lesion of the breast. Mammograms and biopsy are required to assess the condition. As this patient was anemic and presented with bleeding from ulcerative lesion, mastectomy was offered before mammogram was performed. Histopathological and immunohistochemistry (IHC) investigations of the surgical specimen are required to confirm the pathological diagnosis [6]. The tumor is usually composed of spindle cells arranged in a storiform pattern, showing minimal nuclear pleomorphism and low mitotic activity on histopathological specimen. In immunohistochemistry about 90% of cases, DFSP demonstrates CD34 positivity, while it is negative for other markers such as S-100, actin, desmin and limited studies have indicated an association between up-regulation of derived growth factor subunit B(PDGFB) gene and DFSP [12]. In our case 11 mitoses identified in ten high power fields with no representation of malignant glandular elements and there was positive CD34 and S100 were demonstrated on immunohistochemical profile. The current recommended first-line treatment for resectable DFSP is surgical excision, with the goal of achieving complete microscopic clearance and tumor free margin of 2 - 3 cm [4.10]. Mastectomy may be considered in some circumstances particularly when the tumor is big and involves all quadrant of breast. Rouhani et al. reported that patients with DFSP who underwent complete excision had an excellent prognosis with a 5-year-survival rate of 99% [13]. Our case demonstrated a locally aggressive ulcerative lesion involving all four quadrants of the breast with bleeding. Mastectomy was offered with the aim to achieve histologically tumor free margins to prevent local recurrence. The overall efficacy of adjuvant radiotherapy has not been well studied because of the rarity of DFSP [5]. Health education and breast cancer awareness campaign is highly important for women particularly when they come to attend primary health care for any other condition. Though no sign of recurrence was observed within two years in this case. Nevertheless, further follow up is necessary to detect any recurrence.

Conclusion

Dermatofibrosarcoma protuberans of the breast is a rare condition and symptoms may mimic those of breast cancer. Dermatofibrosarcoma protuberans involves all four quadrants of the breast, necessitating a mastectomy. The recommended first-line treatment for resectable Dermatofibrosarcoma protuberans is surgical excision, with tumor free margin.

Declarations

Author Contribution

All authors involved conceptualization; methodology; project administration; visualization; writing of original draft and editing. All authors read and approved of the final manuscript.

Ethics statement

Written informed consent was obtained from the patient’s family for publication of this case report and the accompanying clinical, radiological, operative, and pathological images. Permission was taken from the Clinical Executive Director of Mankweng Academic hospital.

Conflicts of interest

The Authors have no conflict of interests

Funding

No funding was utilized in the preparation of this manuscript

Data availability and Material

No new data was generated or analyzed in this manuscript; Data sharing is not applicable.

Acknowledgement

None

References

  1. Darier S, Ferrand M. Dermatofibrosarcomes progressives etricidivantes on fibrosarcomes de la peau. Ann Dermatol V´en´er´eol 1924; 5:545–62. Google Scholar ↗
  2. Hoffmann E. I. Über das knollentreibende Fibrosarkom der Haut (Dermatofibrosarkoma protuberans). Dermatology 2004;43(1–2):1–28 Google Scholar ↗
  3. Bae SH, Lee JY. Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT. Iran J Radiol. 2016 Feb 23;13(2):e33916. doi: . PMID: 27703659; PMCID: PMC5037929 DOI ↗ Google Scholar ↗
  4. Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013 Feb;30(1):13-28. doi: . PMID: 23327727. DOI ↗ Google Scholar ↗
  5. Chen YT, Tu WT, Lee WR, Huang YC. The efficacy of adjuvant radiotherapy in dermatofibrosarcoma protuberans: a systemic review and meta-analysis. J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1107-14. doi: . Epub 2016 Feb 16. PMID: 26879523. DOI ↗ Google Scholar ↗
  6. Wang Y, Wang Y, Chen R, Tang Z, Liu S. A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature. Biomed Res Int. 2020 Nov 9; 2020:8852182. doi: . PMID: 33224981; PMCID: PMC7671798. DOI ↗ Google Scholar ↗
  7. Safdar F, Ud Din N, Sattar AK, Fatima SS, Idress R. Dermatofibrosarcoma Protuberans of the Breast: A Clinicopathological Study of a Rare Cutaneous Low-Grade Sarcoma. Cureus. 2025 Jan 2;17(1):e76786. doi: . PMID: 39897273; PMCID: PMC11786530 DOI ↗ Google Scholar ↗
  8. Lee SJ; Mahoney, M.C.; Shaughnessy, E. Dermatofibrosarcoma Protuberans of the Breast: Imaging Features and Review of the Literature. Am. J.Roentgenol. 2009, 193, W64–W69, DOI ↗ Google Scholar ↗
  9. Al-Manji Z, Al-Umairi RS. Dermatofibrosarcoma Protuberans Mimicking Primary Breast Neoplasm: A case report and literature review. Sultan Qaboos Univ Med J. 2020 Aug;20(3):e368-e371. doi: . Epub 2020 Oct 5. PMID: 33110655; PMCID: PMC7574798 DOI ↗ Google Scholar ↗
  10. Saiag P, Lebbe C, Brochez L, Emile JF, Forsea AM, Harwood C et al. Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024. Eur J Cancer. 2025 Mar 11; 218:115265. doi: . PMID: 39904126. DOI ↗ Google Scholar ↗
  11. Bhuiyan M; Maele M; Mavhungu R; Ooko F; Breast cancer: Factors influencing late-stage presentation at the Mankweng Hospital breast cancer clinic, Polokwane, Limpopo Province, South Africa; S Afr Med J 2022;112(11b):906-910. DOI ↗ Google Scholar ↗
  12. Sadullahoğlu C, Dere Y, Atasever TR, Öztop MT, Karaaslan Ö. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans. Turk Patoloji Derg. 2017;1(1):223-227. English. doi: . PMID: 28832078. DOI ↗ Google Scholar ↗
  13. Rouhani P, Fletcher CD, Devesa SS, Toro JR. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer. 2008 Aug 1;113(3):616-27. doi: . PMID: 18618615. DOI ↗ Google Scholar ↗